BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 36759557)

  • 21. Key regulators of galectin-glycan interactions.
    Kamili NA; Arthur CM; Gerner-Smidt C; Tafesse E; Blenda A; Dias-Baruffi M; Stowell SR
    Proteomics; 2016 Dec; 16(24):3111-3125. PubMed ID: 27582340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis.
    Perez-Moreno E; Oyanadel C; de la Peña A; Hernández R; Pérez-Molina F; Metz C; González A; Soza A
    Biol Res; 2024 Apr; 57(1):14. PubMed ID: 38570874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival.
    Elola MT; Wolfenstein-Todel C; Troncoso MF; Vasta GR; Rabinovich GA
    Cell Mol Life Sci; 2007 Jul; 64(13):1679-700. PubMed ID: 17497244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.
    Bi S; Earl LA; Jacobs L; Baum LG
    J Biol Chem; 2008 May; 283(18):12248-58. PubMed ID: 18258591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced high-affinity glycoconjugate ligands of galectins.
    Hovorková M; Červený J; Bumba L; Pelantová H; Cvačka J; Křen V; Renaudet O; Goyard D; Bojarová P
    Bioorg Chem; 2023 Feb; 131():106279. PubMed ID: 36446202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy.
    Liu D; Zhu H; Li C
    Biomark Res; 2023 Feb; 11(1):22. PubMed ID: 36814341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions.
    Bonzi J; Bornet O; Betzi S; Kasper BT; Mahal LK; Mancini SJ; Schiff C; Sebban-Kreuzer C; Guerlesquin F; Elantak L
    Nat Commun; 2015 Feb; 6():6194. PubMed ID: 25708191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of Galectin-7 in Cancer.
    Kaur M; Kaur T; Kamboj SS; Singh J
    Asian Pac J Cancer Prev; 2016; 17(2):455-61. PubMed ID: 26925627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of sugar chain recognition by galectins and its involvement in disease-associated glycosylation.
    Arikawa T; Simamura E; Shimada H; Nakamura T; Hatta T; Shoji H
    Congenit Anom (Kyoto); 2014 May; 54(2):77-81. PubMed ID: 24450300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosolic galectin-3 and -8 regulate antibacterial autophagy through differential recognition of host glycans on damaged phagosomes.
    Weng IC; Chen HL; Lo TH; Lin WH; Chen HY; Hsu DK; Liu FT
    Glycobiology; 2018 Jun; 28(6):392-405. PubMed ID: 29800364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways.
    Rabinovich GA; Conejo-García JR
    J Mol Biol; 2016 Aug; 428(16):3266-3281. PubMed ID: 27038510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Galectins in Multiple Myeloma.
    Storti P; Marchica V; Giuliani N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectins as Molecular Targets for Therapeutic Intervention.
    Dings RPM; Miller MC; Griffin RJ; Mayo KH
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.
    Bartolazzi A; Sciacchitano S; D'Alessandria C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectins at a glance.
    Johannes L; Jacob R; Leffler H
    J Cell Sci; 2018 May; 131(9):. PubMed ID: 29717004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectins: An Ancient Family of Carbohydrate Binding Proteins with Modern Functions.
    Verkerke H; Dias-Baruffi M; Cummings RD; Arthur CM; Stowell SR
    Methods Mol Biol; 2022; 2442():1-40. PubMed ID: 35320517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galectin-7 in Epithelial Homeostasis and Carcinomas.
    Advedissian T; Deshayes F; Viguier M
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Galectins in Resistance to Anticancer Therapies.
    Navarro P; Martínez-Bosch N; Blidner AG; Rabinovich GA
    Clin Cancer Res; 2020 Dec; 26(23):6086-6101. PubMed ID: 32709716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases.
    d'Alessandro M; De Vita E; Bergantini L; Mazzei MA; di Valvasone S; Bonizzoli M; Peris A; Sestini P; Bargagli E; Bennett D
    Respir Physiol Neurobiol; 2020 Nov; 282():103546. PubMed ID: 32920057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.